|
Spironolactone/hydrochlorothiazideDrug - Spironolactone/hydrochlorothiazide The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Hydrochlorothiazide; Spironolactone
Strength -
25MG;25MG
Applicant -
WATSON LABS
New Drug Application (NDA) Number -
087398
Product Number -
001
Therapeutic Equivalence (TE) Code -
AB
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
RX
Applicant Full Name -
Watson Laboratories Inc
Spironolactone/hydrochlorothiazide
Spironolactone/hydrochlorothiazide 25mg;25mg Tablet; Oral
Spironolactone W/ Hydrochlorothiazide 25mg;25mg Tablet; Oral Spironolactone W/ Hydrochlorothiazide 25mg;25mg Tablet; Oral Spironolactone W/ Hydrochlorothiazide 25mg;25mg Tablet; Oral Spironolactone W/ Hydrochlorothiazide 25mg;25mg Tablet; Oral Spironolactone W/ Hydrochlorothiazide 25mg;25mg Tablet; Oral Spironolactone W/ Hydrochlorothiazide 25mg;25mg Tablet; Oral Spironolactone W/ Hydrochlorothiazide 25mg;25mg Tablet; Oral Spironolactone W/ Hydrochlorothiazide 25mg;25mg Tablet; Oral Spironolactone W/ Hydrochlorothiazide 25mg;25mg Tablet; Oral NewDrugInformation |